Th1/17 Polarization of CD4 T Cells Supports HIV-1 Persistence during Antiretroviral Therapy

被引:85
|
作者
Sun, Hong [1 ,2 ]
Kim, Dhohyung [1 ]
Li, Xiaodong [1 ]
Kiselinova, Maja [1 ,3 ,4 ]
Ouyang, Zhengyu [1 ]
Vandekerckhove, Linos
Shang, Hong [2 ]
Rosenberg, Eric S. [5 ]
Yu, Xu G. [1 ]
Lichterfeld, Mathias [1 ,5 ,6 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] China Med Univ, Affiliated Hosp 1, Key Lab AIDS Immunol, Natl Hlth & Family Planning Commiss, Shenyang, Peoples R China
[3] Univ Ghent, HIV Translat Res Unit, B-9000 Ghent, Belgium
[4] Univ Hosp, Ghent, Belgium
[5] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSCRIPTION FACTOR GATA-3; TH17; CELLS; GENE-EXPRESSION; RESERVOIR; INFECTION; LATENT; DIFFERENTIATION; IDENTIFICATION;
D O I
10.1128/JVI.01595-15
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The ability to persist long term in latently infected CD4 T cells represents a characteristic feature of HIV-1 infection and the predominant barrier to efforts aiming at viral eradication and cure. Yet, increasing evidence suggests that only small subsets of CD4 T cells with specific developmental and maturational profiles are able to effectively support HIV-1 long-term persistence. Here, we analyzed how the functional polarization of CD4 T cells shapes and structures the reservoirs of HIV-1-infected cells. We found that CD4 T cells enriched for a Th1/17 polarization had elevated susceptibilities to HIV-1 infection in ex vivo assays, harbored high levels of HIV-1 DNA in persons treated with antiretroviral therapy, and made a disproportionately increased contribution to the viral reservoir relative to their contribution to the CD4 T memory cell pool. Moreover, HIV-1 DNA levels in Th1/17 cells remained stable over many years of antiretroviral therapy, resulting in a progressively increasing contribution of these cells to the viral reservoir, and phylogenetic studies suggested preferential long-term persistence of identical viral sequences during prolonged antiretroviral treatment in this cell compartment. Together, these data suggest that Th1/17 CD4 T cells represent a preferred site for HIV-1 DNA long-term persistence in patients receiving antiretroviral therapy. IMPORTANCE Current antiretroviral therapy is very effective in suppressing active HIV-1 replication but does not fully eliminate virally infected cells. The ability of HIV-1 to persist long term despite suppressive antiretroviral combination therapy represents a perplexing aspect of HIV-1 disease pathogenesis, since most HIV-1 target cells are activated, short-lived CD4 T cells. This study suggests that CD4 T helper cells with Th1/17 polarization have a preferential role as a long-term reservoir for HIV-1 infection during antiretroviral therapy, possibly because these cells may imitate some of the functional properties traditionally attributed to stem cells, such as the ability to persist for extremely long periods of time and to repopulate their own pool size through homeostatic self-renewal. These observations support the hypothesis that HIV-1 persistence is driven by small subsets of long-lasting stem cell-like CD4 T cells that may represent particularly promising targets for clinical strategies aiming at HIV-1 eradication and cure.
引用
收藏
页码:11284 / 11293
页数:10
相关论文
共 50 条
  • [1] Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy
    Galvez, Cristina
    Grau-Exposito, Judith
    Urrea, Victor
    Clotet, Bonaventura
    Falco, Vicenc
    Buzon, Maria Jose
    Martinez-Picado, Javier
    MBIO, 2021, 12 (06):
  • [2] Role of endothelin-1 and angiotensin II in the polarization of CD4 memory T cells into Th1 and Th17
    Caillon, A.
    Grenier, C.
    Loufrani, L.
    Jeannin, P.
    Henrion, D.
    Delneste, Y.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 : 79 - 79
  • [3] Caspase-1 Activity in CD4 T Cells Is Downregulated Following Antiretroviral Therapy for HIV-1 Infection
    Cai, Rentian
    Liu, Li
    Luo, Bin
    Wang, Jiangrong
    Shen, Jiayin
    Shen, Yinzhong
    Zhang, Renfang
    Chen, Jun
    Lu, Hongzhou
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2017, 33 (02) : 164 - 171
  • [4] New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
    Wacleche, Vanessa Sue
    Goulet, Jean-Philippe
    Gosselin, Annie
    Monteiro, Patricia
    Soudeyns, Hugo
    Fromentin, Remi
    Jenabian, Mohammad-Ali
    Vartanian, Shant
    Deeks, Steven G.
    Chomont, Nicolas
    Routy, Jean-Pierre
    Ancuta, Petronela
    RETROVIROLOGY, 2016, 13
  • [5] New insights into the heterogeneity of Th17 subsets contributing to HIV-1 persistence during antiretroviral therapy
    Vanessa Sue Wacleche
    Jean-Philippe Goulet
    Annie Gosselin
    Patricia Monteiro
    Hugo Soudeyns
    Rémi Fromentin
    Mohammad-Ali Jenabian
    Shant Vartanian
    Steven G. Deeks
    Nicolas Chomont
    Jean-Pierre Routy
    Petronela Ancuta
    Retrovirology, 13
  • [6] Rapid restoration of CD4 T cell subsets in subjects receiving antiretroviral therapy during primary HIV-1 infection
    Kaufmann, GR
    Zaunders, JJ
    Cunningham, P
    Kelleher, AD
    Grey, P
    Smith, D
    Carr, A
    Cooper, DA
    AIDS, 2000, 14 (17) : 2643 - 2651
  • [7] HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy
    Sterling, TR
    Chaisson, RE
    Moore, RD
    AIDS, 2001, 15 (17) : 2251 - 2257
  • [8] ALCOHOL PROMOTES DIFFERENTIATION OF CD4 T CELLS TO PROINFLAMMATORY TH1 CELLS
    McTernan, P. M.
    Siggins, R. W.
    Simon, L.
    Molina, P. E.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 : 218A - 218A
  • [9] Astrocytes Modulate the Polarization of CD4+ T Cells to Th1 Cells
    Beurel, Eleonore
    Harrington, Laurie E.
    Buchser, William
    Lemmon, Vance
    Jope, Richard S.
    PLOS ONE, 2014, 9 (01):
  • [10] Persistence of intact HIV-1 proviruses in the brain during antiretroviral therapy
    Sun, Weiwei
    Rassadkina, Yelizaveta
    Gao, Ce
    Collens, Sarah Isabel
    Lian, Xiaodong
    Solomon, Isaac H.
    Mukerji, Shibani S.
    Yu, Xu G.
    Lichterfeld, Mathias
    ELIFE, 2023, 12